ARCHIVES

In Brief: Healy To Use 1 Percent Transfer Authority For TB Research; Zoon Heads FDA’s CBER

This article is from The Cancer Letter archive.

Vol. 18 No. 12 | March 20, 1992

Download PDF Visit The Full Archive

Related Articles

Pretreatment with Azacitidine Achieves 28-Month Remission

August 30, 2013

Drugs and Targets: Cyramza approved in metastatic stomach cancer

November 7, 2014

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992

Lung Screening Advocates Say Verdict’s In, Attack NCI Randomized Trial As “Outdated.”

November 3, 2006

ACS Concludes That Laetrile Organization Is Insignificant

November 29, 1991

Also in this 12-page issue: NCI’s Lance Liotta and FDA’s Emanuel Petricoin to move to George Mason University.

March 11, 2005